LeMaitre Vascular
LMAT
44 hedge funds and large institutions have $49.5M invested in LeMaitre Vascular in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 4 closing their positions.
129% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 7
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
2% more capital invested
Capital invested by funds: $48.3M → $49.5M (+$1.12M)
0% more funds holding
Funds holding: 44 → 44 (0)
Top Buyers
Top Sellers
LMAT Hedge Fund Activity: Q1 2014 in Review
44 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2014, worth a combined $49.5M — up 2.3% from $48.3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LMAT positions and 4 closed out — a net gain of 1 holder — while 16 added to existing stakes and 7 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.61M. The largest seller was Wellington Management Group, cutting an estimated $1.88M.
- 44 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $49.5M of LeMaitre Vascular stock for Q1 2014, up 2.3% quarter-over-quarter.
- 5 funds opened new LeMaitre Vascular positions in Q1 2014 and 4 closed out, a net change of +1 holder.
- The largest LeMaitre Vascular buyer in Q1 2014 was Millennium Management, an estimated $1.61M added.
- The largest LeMaitre Vascular seller in Q1 2014 was Wellington Management Group, an estimated $1.88M sold.
Based on aggregated 13F filings for Q1 2014.